Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Scott Braunstein
AddedFeb 17, 2024
UpdatedMay 31, 2026
Scott Braunstein

Scott Braunstein

Board Member, Caribou Biosciences

CrunchbaseLinkedInThe Org

Scott Braunstein's Career

Caribou Biosciences
Caribou Biosciences

Berkeley, CA, US

Board Member· Board
Marinus Pharmaceuticals
Marinus Pharmaceuticals

Radnor, PA, US

Board Member· Board
Trevena
Trevena

King of Prussia, PA, US

Board Member· Board
SiteOne Therapeutics
SiteOne Therapeutics

Bozeman, MT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Scott Braunstein's Career

Caribou Biosciences
Caribou Biosciences
Public$317.7M1372011Berkeley, CA, US
Board Member· Board

Leadership at Caribou Biosciences

Santhosh PalaniSanthosh PalaniBoard Member
Jennifer DoudnaJennifer DoudnaCo-Founder
Martin JinekMartin JinekCo-Founder
Rodolphe BarrangouRodolphe BarrangouBoard Member
Rachel HaurwitzRachel HaurwitzBoard Member
Ran ZhengRan ZhengBoard Member
Marinus Pharmaceuticals
Marinus Pharmaceuticals

Radnor, PA, US

Board Member· Board
Trevena
Trevena
Public$546.6M352007King of Prussia, PA, US
Board Member· Board

Leadership at Trevena

Jake NunnJake NunnBoard Member
Robert LefkowitzRobert LefkowitzCo-Founder
Howard RockmanHoward RockmanBoard Member
Lonnie MoulderLonnie MoulderBoard Member
Carrie L. BourdowCarrie L. BourdowBoard Member
Mark H N CorriganMark H N CorriganBoard Member

Similar to Trevena

Tremeau PharmaceuticalsTremeau PharmaceuticalsConcord, MA, USPain Therapiesest. 2016Tremeau PharmaceuticalsConcord, MA, US · est. 2016

Massachusetts-based pharmaceutical company specializing in non-opioid pain therapies.

Private Equity · $115.2M11
TrigeminaTrigeminaMoraga, CA, USPain Treatmentsest. 2006TrigeminaMoraga, CA, US · est. 2006

Trigemina, Inc.: A US-based pharmaceutical company innovating non-opiate pain therapies.

Series A · $27.6M11
Tris PharmaTris PharmaMonmouth Junction, NJ, USPharmaceuticalsest. 2000Tris PharmaMonmouth Junction, NJ, US · est. 2000

Tris Pharma, a New Jersey-based medical organization, innovates drug delivery technologies and medicines for disease treatment.

Public · $141.6M350
Neurana PharmaceuticalsNeurana PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2013Neurana PharmaceuticalsSan Diego, CA, US · est. 2013

Neurana Pharmaceuticals: A US-based specialty pharma company innovating treatments for CNS diseases.

Series A · $60M5
SiteOne Therapeutics
SiteOne Therapeutics
Series B$34.2M52010Bozeman, MT, US
Board Member· Board

Leadership at SiteOne Therapeutics

Stan AbelStan AbelBoard Member
John MulcahyJohn MulcahyCo-Founder
George MiljanichGeorge MiljanichCo-Founder
Will PriceWill PriceBoard Member
John MulcahyJohn MulcahyCEO
Lowell SearsLowell SearsBoard Member

Scott Braunstein's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Scott Braunstein

Cara JonesCara JonesCo-Founder · Marinus AnalyticsShalin ShahShalin ShahCEO · Marius PharmaceuticalsRobert BaffiRobert BaffiBoard Member · NeurogeneHimanshu H. ShahHimanshu H. ShahBoard Member · Marius PharmaceuticalsPaul GrintPaul GrintBoard Member · Inhibikase TherapeuticsChris ViehbacherChris ViehbacherBoard Member · Before Brands